KalVista Pharmaceuticals | 4:持股变动声明-董事 Fairey William
KalVista Pharmaceuticals | 3:首次持股声明-董事 Fairey William
KalVista Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-TCG Crossover GP I, LLC(3.2%),TCG Crossover Fund I, L.P.(3.2%)等
KalVista Pharmaceuticals | 4:持股变动声明-高管 Palleiko Benjamin L
KalVista Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Adage Capital Partners, L.P.(6.87%),Adage Capital Partners GP, L.L.C.(6.87%)等
KalVista Pharmaceuticals | 4:持股变动声明-股东 Venrock Healthcare Capital Partners III, L.P.
KalVista Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-James N. Topper(8.9%),Patrick J. Heron(8.9%)等
KalVista Pharmaceuticals | 4:持股变动声明-高管 Feener Edward P.
KalVista Pharmaceuticals | 4:持股变动声明-高管 Yea Christopher
KalVista Pharmaceuticals | 4:持股变动声明-高管 Palleiko Benjamin L
KalVista Pharmaceuticals | 4:持股变动声明-高管 Audhya Paul K.
KalVista Pharmaceuticals | 4:持股变动声明-高管 Crockett Thomas Andrew
KalVista Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-TCG Crossover GP I, LLC(6.52%),TCG Crossover Fund I, L.P.(6.52%)等
KalVista Pharmaceuticals | 4:持股变动声明-高管 Yea Christopher
KalVista Pharmaceuticals | 4:持股变动声明-高管 Crockett Thomas Andrew
KalVista Pharmaceuticals | 4:持股变动声明-高管 Palleiko Benjamin L
KalVista Pharmaceuticals | 4:持股变动声明-高管 Feener Edward P.
KalVista Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-TANG CAPITAL PARTNERS, LP(9.96%),Tang Capital Management, LLC(9.96%)等
KalVista Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(14.0%),VHCP Co-Investment Holdings III, LLC(14.0%)等
KalVista Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Suvretta Capital Management, LLC(7.8%),Aaron Cowen(7.8%)等
暂无数据